Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-05-18

Clinical Trial Update: IV Ascorbic Acid in Advanced Gastric Cancer [Phase 3]

View source ↗

Summary

This document provides an update on a Phase 3 trial evaluating intravenous ascorbic acid in advanced gastric cancer, sponsored by Sun Yat-sen University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IV ascorbic acid (ascorbic acid)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Gastric Cancer | Phase 3 | Status: UNKNOWN